Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORA | P35398 | 1/20 | 0.48 |
| ▸ | RORC | P51449 | 1/20 | 0.48 |
| ▸ | RORB | Q92753 | 1/20 | 0.48 |
| ▸ | FAAH | O00519 | 1/20 | 0.46 |
| ▸ | MGLL | Q99685 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 2/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.42 |
| ▸ | TACR2 | P21452 | 2/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.42 |
| ▸ | HTR2A | P28223 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | SHBG | P04278 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18858863 | 1.00 | RORA (0.48) | RORARORCRORBFAAHMGLL | |
| SCHEMBL14107128 | 1.00 | RORA (0.48) | RORARORCRORBFAAHMGLL | |
| SCHEMBL15385939 | 0.96 | RORA (0.47) | RORARORCRORBFAAHMGLL | |
| SCHEMBL17248306 | 0.94 | KDM4E (0.46) | RORARORCRORBFAAHMGLL | |
| SCHEMBL15165490 | 0.94 | MGLL (0.50) | RORARORCRORBFAAHMGLL | |
| SCHEMBL9901489 | 0.91 | RORA (0.42) | RORARORCRORBFAAHMGLL | |
| SCHEMBL9901161 | 0.90 | HSD11B1 (0.42) | RORARORCRORBFAAHMGLL | |
| SCHEMBL25297485 | 0.88 | RORA (0.46) | RORARORCRORBFAAHMGLL | |
| SCHEMBL25785325 | 0.88 | RORA (0.46) | RORARORCRORBFAAHMGLL | |
| SCHEMBL14325105 | 0.88 | RORA (0.46) | RORARORCRORBFAAHMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9714253-B2 | Organic thin film transistor, organic semiconductor thin film, and organic semiconductor material | FUJIFILM CORPORATION (JP) | 2017-07-25 | — | — | US | disclosed |
| US-20150166561-A1 | ORGANIC THIN FILM TRANSISTOR, ORGANIC SEMICONDUCTOR THIN FILM, AND ORGANIC SEMICONDUCTOR MATERIAL | FUJIFILM CORPORATION (JP) | 2015-06-18 | — | — | US | disclosed |
| US-20140088313-A1 | SUBSTITUTED INDOLOCARBAZOLES | XEROX CORPORATION (US) | 2014-03-27 | — | — | US | disclosed |
| US-20140088313-A1 | SUBSTITUTED INDOLOCARBAZOLES | XEROX CORPORATION (US) | 2014-03-27 | — | — | US | disclosed |
| US-8609867-B2 | Substituted indolocarbazoles | XEROX CORPORATION (US) | 2013-12-17 | — | — | US | disclosed |
| US-20130320269-A1 | PROCESS FOR THE PREPARATION OF SEMICONDUCTOR MATERIALS, COMPOUNDS AND THEIR USE | THE UNIVERSITY OF MANCHESTER (GB) | 2013-12-05 | — | — | US | disclosed |
| EP-2649073-A2 | PROCESS FOR THE PREPARATION OF SEMICONDUCTOR MATERIALS, COMPOUNDS AND THEIR USE | The University Of Manchester (GB) | 2013-10-16 | — | — | EP | disclosed |
| EP-1671998-B1 | Process to form compound with indolocarbazole moieties | XEROX CORP (US) | 2013-02-20 | — | — | EP | disclosed |
| US-20120157689-A1 | SUBSTITUTED INDOLOCARBAZOLES | XEROX CORPORATION (US) | 2012-06-21 | — | — | US | disclosed |
| US-20120157689-A1 | SUBSTITUTED INDOLOCARBAZOLES | XEROX CORPORATION (US) | 2012-06-21 | — | — | US | disclosed |
| US-7402681-B2 | Compound with indolocarbazole moieties and devices containing such compound | XEROX CORPORATION (US) | 2008-07-22 | — | — | US | disclosed |
| US-7173140-B2 | Process to form compound with indolocarbazole moieties | XEROX CORPORATION (US) | 2007-02-06 | — | — | US | disclosed |
| US-7173140-B2 | Process to form compound with indolocarbazole moieties | XEROX CORPORATION (US) | 2007-02-06 | — | — | US | disclosed |
| US-20060214155-A1 | Compound with indolocarbazole moieties and devices containing such compound | XEROX CORPORATION | 2006-09-28 | — | — | US | disclosed |
| EP-1672713-A1 | Compound with indolocarbazole moieties and electronic devices containing such compound | Xerox Corporation (US) | 2006-06-21 | — | — | EP | disclosed |
| EP-1671998-A2 | Process to form compound with indolocarbazole moieties | Xerox Corporation (US) | 2006-06-21 | — | — | EP | disclosed |
| US-20060124923-A1 | Thin film transistors including indolocarbazoles | XEROX CORPORATION | 2006-06-15 | — | — | US | disclosed |
| US-20060124921-A1 | Compound with indolocarbazole moieties and devices containing such compound | XEROX CORPORATION (US) | 2006-06-15 | — | — | US | disclosed |
| US-20060125009-A1 | Thin film transistors including indolocarbazoles | XEROX CORPORATION | 2006-06-15 | — | — | US | disclosed |
| US-20060128969-A1 | Process to form compound with indolocarbazole moieties | XEROX CORPORATION | 2006-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150166561-A1 | ORGANIC THIN FILM TRANSISTOR, ORGANIC SEMICONDUCTOR THIN FILM, AND ORGANIC SEMICONDUCTOR MATERIAL | TRMT1L, APOL1, TLL1 | RORA 3919/4885RORC 4262/4885RORB 4218/4885 |
| US-20060128969-A1 | Process to form compound with indolocarbazole moieties | INMT, CYP3A4, PLK1 | RORA 1281/4885RORC 497/4885RORB 1172/4885 |
| US-20060214155-A1 | Compound with indolocarbazole moieties and devices containing such compound | BRD4, INO80C, BICRA | RORA 1210/4885RORC 383/4885RORB 982/4885 |
| US-20060124921-A1 | Compound with indolocarbazole moieties and devices containing such compound | BRD4, INO80C, BICRA | RORA 1210/4885RORC 383/4885RORB 982/4885 |
| US-20120157689-A1 | SUBSTITUTED INDOLOCARBAZOLES | HTR3C, HTR3A, AANAT | RORA 577/4885RORC 241/4885RORB 424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.